Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37655

H2AJ Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The H2AJ Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of HeLa cells (HPV18-positive; p53 and RB1 inactivated) with targeted disruption of the H2A.J gene, which encodes a senescence-associated histone H2A variant. This model enables study of SAHF formation and stable gene silencing in a widely used cervical adenocarcinoma line. H2A.J is transcriptionally controlled by DNA damage?Cresponsive kinases ATM and ATR and interacts with chromatin factors including HP1?? and ATRX to repress proliferation genes like CCNA2. Typical applications involve western blotting, senescence ??-galactosidase assays, immunofluorescence for SAHF markers, and ChIP?CqPCR, supporting cancer epigenetics and aging research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    H2AJ

    Gene Identifier

    NCBI Gene ID 55766

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The H2AJ Knockout HeLa Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal cell population featuring targeted disruption of the human H2AJ gene, which encodes a replication-independent histone H2A variant that accumulates during cellular senescence. This loss-of-function model enables robust investigation of H2AJ-dependent chromatin remodeling and senescence programs without clonal selection, preserving the biological heterogeneity characteristic of senescent cell populations.

The host HeLa line is a human cervical adenocarcinoma epithelial cell model that is HPV18-positive. Constitutive expression of viral oncoproteins E6 and E7 inactivates the tumor suppressors p53 and retinoblastoma protein (RB1) through ubiquitin-mediated degradation, thereby abrogating the p53/p21 and p16/RB1 pathways. This genetic background provides a permissive environment for studying senescence mechanisms independent of canonical tumor suppressor checkpoints.

H2A.J transcription is induced by DNA damage?Cactivated kinases ATM and ATR and is further regulated by p53 and the cyclin-dependent kinase inhibitors p21 and p16. The histone variant is incorporated into chromatin, where it interacts with linker histone H1, HP1??, macroH2A, and the chromatin remodelers ATRX and DAXX to promote the assembly of senescence-associated heterochromatic foci (SAHF). These repressive domains mediate stable silencing of proliferation-associated genes such as CCNA2 and CCNB1, thereby reinforcing the senescent cell-cycle arrest and modulating the senescence-associated secretory phenotype (SASP).

In HeLa cells, where p53 and RB1 are functionally compromised, H2AJ disruption offers a unique tool to dissect p53/RB1-independent contributions of histone variant dynamics to SAHF formation and gene silencing. The model allows interrogation of whether H2A.J can drive chromatin compaction and proliferation arrest in the absence of canonical tumor suppressors, enabling the study of compensatory pathways involving p21, p16, or other stress-responsive factors. This context is particularly useful for exploring oncogene-induced or oxidative stress?Ctriggered senescence programs that may operate outside the classical p53/RB1 axis.

The polyclonal knockout cells are suitable for senescence and chromatin biology assays, including western blotting for H2A.J, senescence-associated ??-galactosidase staining, and immunofluorescence for SAHF markers (H3K9me3, HP1??). ChIP-qPCR maps H2A.J chromatin occupancy, while RNA-seq reveals transcriptional derepression of cell-cycle genes like CCNA2 and SASP components. Flow cytometry for cell cycle analysis quantifies proliferation changes. These applications support drug discovery, aging research, and cancer epigenetics. For further details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)